Calgenex’ Dermalleve
This article was originally published in The Tan Sheet
Executive Summary
Tampa, Fla.-based Calgenex announces the launch of Dermalleve, an over-the-counter topical treatment for psoriasis, eczema and seborrheic dermatitis that combines 1% hydrocortisone with natural ingredients to moisturize and nourish skin, the firm states Sept. 27. The product contains natural ingredients such as alpha-hydroxy acids, skin-nourishing nutrients and skin conditioners such as aloe vera, shea butter, vitamin E, jojoba oil and silicone. The product "helps to gently remove dead skin cells while skin-nourishing nutrients, conditioners and moisturizers support healthy skin," Calgenex says. Demalleve also applies easily and evenly because it has the consistency of a lubricant unlike other anti-itch creams which can be too thick, the company asserts. The product is available on Calgenex's website for $19.95 and the firm is supporting the launch with radio ads and TV infomercials...
You may also be interested in...
Pink Sheet Podcast: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development
Pink Sheet editors discuss Medicare spending projections for the Alzheimer’s treatment Leqembi, Janet Woodcock’s new post-FDA role, and ongoing preparations for new pneumococcal vaccines that will reach the market soon.
Investors Go Berserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.